$0.67 EPS Expected for Masonite International (DOOR); Broderick Brian C Has Trimmed Bristol (BMY) Stake

April 10, 2018 - By wolcottdaily

Masonite International Corporation (NYSE:DOOR) Logo

Broderick Brian C decreased Bristol (BMY) stake by 33.59% reported in 2017Q4 SEC filing. Broderick Brian C sold 7,470 shares as Bristol (BMY)’s stock rose 2.38%. The Broderick Brian C holds 14,770 shares with $905,000 value, down from 22,240 last quarter. Bristol now has $99.48 billion valuation. The stock increased 0.60% or $0.365 during the last trading session, reaching $60.845. About 3.87M shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has risen 11.37% since April 10, 2017 and is uptrending. It has underperformed by 0.18% the S&P500.

Analysts expect Masonite International Corporation (NYSE:DOOR) to report $0.67 EPS on May, 14.They anticipate $0.11 EPS change or 14.10% from last quarter’s $0.78 EPS. DOOR’s profit would be $18.76 million giving it 22.82 P/E if the $0.67 EPS is correct. After having $0.71 EPS previously, Masonite International Corporation’s analysts see -5.63% EPS growth. The stock increased 0.99% or $0.6 during the last trading session, reaching $61.15. About 136,972 shares traded. Masonite International Corporation (NYSE:DOOR) has declined 25.06% since April 10, 2017 and is downtrending. It has underperformed by 36.61% the S&P500.

Since February 26, 2018, it had 0 buys, and 1 insider sale for $197,250 activity. Lewis Robert Edgar also sold $197,250 worth of Masonite International Corporation (NYSE:DOOR) on Monday, February 26.

Among 10 analysts covering Masonite International (NYSE:DOOR), 6 have Buy rating, 0 Sell and 4 Hold. Therefore 60% are positive. Masonite International had 34 analyst reports since August 21, 2015 according to SRatingsIntel. The stock has “Buy” rating by RBC Capital Markets on Monday, June 19. On Friday, August 11 the stock rating was downgraded by Stifel Nicolaus to “Hold”. RBC Capital Markets maintained the stock with “Outperform” rating in Wednesday, March 8 report. Nomura maintained Masonite International Corporation (NYSE:DOOR) on Thursday, August 10 with “Buy” rating. The stock of Masonite International Corporation (NYSE:DOOR) has “Overweight” rating given on Tuesday, December 15 by JP Morgan. On Friday, November 6 the stock rating was maintained by RBC Capital Markets with “Outperform”. FBR Capital maintained it with “Outperform” rating and $87.0 target in Tuesday, August 25 report. The firm has “Outperform” rating given on Friday, February 24 by Wedbush. The firm has “Buy” rating given on Thursday, November 9 by RBC Capital Markets. The firm earned “Equal-Weight” rating on Thursday, August 10 by Stephens.

Masonite International Corporation designs, makes, and sells interior and exterior doors for the new construction and repair, renovation, and remodeling sectors of the residential and non-residential building construction markets worldwide. The company has market cap of $1.71 billion. It offers molded panel, flush, stile and rail, routed medium-density fiberboard , steel, or fiberglass residential doors. It has a 12.01 P/E ratio. The firm also provides various door components, including interior door facings, agri-fiber and particleboard door cores, MDFs, wood cut-stock components, critical door components, wood veneer door skins, and mineral and particleboard door cores.

Investors sentiment increased to 1.29 in Q4 2017. Its up 0.10, from 1.19 in 2017Q3. It is positive, as 15 investors sold Masonite International Corporation shares while 53 reduced holdings. 35 funds opened positions while 53 raised stakes. 25.97 million shares or 4.88% less from 27.30 million shares in 2017Q3 were reported. National Bank & Trust Of Ny Mellon owns 0% invested in Masonite International Corporation (NYSE:DOOR) for 149,030 shares. State Common Retirement Fund stated it has 0.01% of its portfolio in Masonite International Corporation (NYSE:DOOR). Art Ltd Limited Liability Company owns 20,330 shares. American Century holds 0% or 58,662 shares. Assetmark has invested 0% in Masonite International Corporation (NYSE:DOOR). Amalgamated Financial Bank owns 0.01% invested in Masonite International Corporation (NYSE:DOOR) for 3,863 shares. Aurora Inv Counsel holds 0.71% or 19,273 shares in its portfolio. Great Lakes Advisors Limited Liability Company has 0.07% invested in Masonite International Corporation (NYSE:DOOR). Walleye Trading Ltd Co holds 0% in Masonite International Corporation (NYSE:DOOR) or 4,212 shares. Macquarie Group Incorporated Limited has 22,484 shares. D E Shaw Communications owns 225,155 shares for 0.02% of their portfolio. Emerald Advisers Inc Pa owns 181,206 shares or 0.52% of their US portfolio. Neuberger Berman Gru Lc has invested 0.07% of its portfolio in Masonite International Corporation (NYSE:DOOR). Hbk Lp invested in 4,128 shares. Rothschild Asset Mgmt owns 31,080 shares.

Among 22 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 8 have Buy rating, 3 Sell and 11 Hold. Therefore 36% are positive. Bristol-Myers Squibb Company had 78 analyst reports since July 28, 2015 according to SRatingsIntel. Jefferies maintained the stock with “Buy” rating in Friday, September 15 report. The company was maintained on Friday, October 27 by Credit Suisse. Cowen & Co maintained Bristol-Myers Squibb Company (NYSE:BMY) rating on Monday, July 10. Cowen & Co has “Hold” rating and $6500 target. The firm earned “Buy” rating on Tuesday, September 20 by Citigroup. Cowen & Co maintained the stock with “Hold” rating in Monday, August 14 report. The firm earned “Buy” rating on Friday, February 16 by Citigroup. Bank of America maintained it with “Neutral” rating and $68 target in Monday, March 5 report. As per Friday, September 9, the company rating was maintained by Barclays Capital. Jefferies maintained the stock with “Hold” rating in Thursday, November 16 report. UBS upgraded Bristol-Myers Squibb Company (NYSE:BMY) rating on Tuesday, September 29. UBS has “Buy” rating and $75 target.

Analysts await Bristol-Myers Squibb Company (NYSE:BMY) to report earnings on April, 26. They expect $0.86 earnings per share, up 2.38% or $0.02 from last year’s $0.84 per share. BMY’s profit will be $1.41B for 17.69 P/E if the $0.86 EPS becomes a reality. After $0.68 actual earnings per share reported by Bristol-Myers Squibb Company for the previous quarter, Wall Street now forecasts 26.47% EPS growth.

Since December 12, 2017, it had 1 buying transaction, and 1 insider sale for $85,985 activity. Another trade for 4,000 shares valued at $249,187 was made by Samuels Theodore R. II on Friday, December 15. Lynch Thomas J. Jr. sold 5,300 shares worth $335,172.

Broderick Brian C increased Aqr Multi Strgy Alternative Cl stake by 34,852 shares to 458,736 valued at $4.15M in 2017Q4. It also upped Fortive Corp stake by 11,213 shares and now owns 44,601 shares. Fpa Crescent Fund (FPACX) was raised too.

Investors sentiment decreased to 0.94 in 2017 Q4. Its down 0.09, from 1.03 in 2017Q3. It fall, as 72 investors sold BMY shares while 526 reduced holdings. 106 funds opened positions while 457 raised stakes. 1.11 billion shares or 0.48% more from 1.11 billion shares in 2017Q3 were reported. Amer Bankshares has invested 0.11% in Bristol-Myers Squibb Company (NYSE:BMY). Westpac Banking reported 0.26% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Logan accumulated 9,194 shares. Clearbridge Limited Liability Com holds 565,980 shares or 0.72% of its portfolio. Hourglass Cap Ltd Liability Company reported 6,149 shares stake. North Mgmt holds 0.1% or 10,400 shares in its portfolio. Founders Cap Mngmt Ltd Liability Company has 0.11% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 4,123 shares. Moreover, Headinvest Ltd Company has 0.24% invested in Bristol-Myers Squibb Company (NYSE:BMY). Toronto Dominion Bankshares accumulated 718,449 shares. Dynamic Advsr Solutions Limited Company holds 0.34% in Bristol-Myers Squibb Company (NYSE:BMY) or 16,723 shares. Neville Rodie And Shaw Incorporated invested in 94,838 shares or 0.61% of the stock. Regions Financial reported 843,683 shares. Bluemountain Cap Mgmt Ltd Liability Com has 142,855 shares for 0.18% of their portfolio. Covington Cap Mgmt holds 59,914 shares. Kcm Invest Advsrs Limited Com has 282,545 shares.

Bristol-Myers Squibb Company (NYSE:BMY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.